XOMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.44 USD | +7.39% |
|
+2.66% | +37.51% |
| May. 09 | Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M | MT |
| May. 09 | XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechJason Kantor (Analysts)Okay, terrific. Get started here. Keep things rolling o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
XOMA Corporation is a biotechnology royalty aggregator. The Companyâs royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Its royalty portfolio includes DAY101 (tovorafenib), JNJ-63723283 (cetrelimab), RZ358, arimoclomol, TAK-079 (mezagitamab), BAY-1213790 (osocimab), AFM13 (acimtamig), AB023 (gruticibart), AB002 (E-WE thrombin), AB054, AV-299 (ficlatuzumab), COM902, vosaroxin, aldoxorubicin, INCAGN2385, INCAGN02390, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, G03-52-01, RZ402, DSUVIA (sufentanil sublingual tablet), IXINITY [coagulation factor IX (recombinant)], VABYSMO (faricimab-svoa), CMP-001 (vidutolimod), and CFZ533 (iscalimab).
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
25.44
USD
Average target price
58
USD
Spread / Average Target
+127.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +37.51% | 296M | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| -0.03% | 22.25B | |
| -13.14% | 22.09B | |
| -7.96% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
- Stock Market
- Equities
- XOMA Stock
- News XOMA Corporation
- Transcript : XOMA Corporation Presents at Credit Suisse Annual Healthcare Conference, Nov-12-2014 04
